← Back to Analyst Consensus 
ASTH Buy
Astrana Health, Inc.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Sep 15, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Aug 11, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Aug 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 14, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 14, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 2, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 26, 2026 | Barclays | upgrade | Equal-Weight → Overweight | — | 53% |
| May 14, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| May 12, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 11, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| May 8, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 8, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Apr 15, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 55% |
| Feb 2, 2026 | BTIG | maintain | Buy → Buy | $40 | 52% |
| Dec 12, 2025 | Needham | initiate | — → Buy | $28 | 50% |
| Nov 25, 2025 | Jefferies | maintain | Buy → Buy | $37 | 52% |
| Nov 24, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $26 | 53% |
| Nov 10, 2025 | TD Cowen | maintain | Buy → Buy | $35 | 54% |
| Nov 7, 2025 | BTIG | maintain | Buy → Buy | $45 | 52% |
| Apr 1, 2025 | Barclays | initiate | — → Equal-Weight | $36 | 53% |
| Mar 18, 2025 | Truist Securities | maintain | Buy → Buy | $46 | 55% |
| Mar 4, 2025 | B of A Securities | maintain | Buy → Buy | $49 | 53% |
| Mar 3, 2025 | Baird | maintain | Outperform → Outperform | $50 | 55% |
| Feb 20, 2025 | Stifel | maintain | Buy → Buy | $56 | 53% |
| Jan 13, 2025 | Truist Securities | maintain | Buy → Buy | $50 | 55% |
| Nov 13, 2024 | Baird | maintain | Outperform → Outperform | $86 | 55% |
| Oct 14, 2024 | TD Cowen | initiate | — → Buy | $66 | 54% |
| Oct 11, 2024 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| Oct 3, 2024 | BTIG | maintain | Buy → Buy | $70 | 52% |
| Aug 15, 2024 | Baird | maintain | Outperform → Outperform | $67 | 55% |
| Aug 9, 2024 | Truist Securities | maintain | Buy → Buy | $59 | 55% |
| Aug 1, 2024 | Stifel | maintain | Buy → Buy | $60 | 53% |
| Jul 11, 2024 | Truist Securities | upgrade | Hold → Buy | $50 | 55% |
| Jun 27, 2024 | Stifel | maintain | Buy → Buy | $48 | 53% |
| May 30, 2024 | Baird | initiate | — → Outperform | $54 | 55% |
| May 8, 2024 | Stifel | maintain | Buy → Buy | $45 | 53% |
| Mar 1, 2024 | Truist Securities | maintain | Hold → Hold | $44 | 55% |
| Feb 26, 2024 | Jefferies | initiate | — → Buy | $50 | 52% |
| Feb 22, 2024 | B of A Securities | upgrade | Neutral → Buy | $55 | 53% |
| Jan 24, 2024 | Stifel | initiate | — → Buy | $45 | 53% |
| Dec 22, 2023 | Truist Securities | initiate | — → Hold | $41 | 55% |
| Oct 17, 2023 | BTIG | initiate | — → Buy | $45 | 52% |
| Apr 12, 2023 | B of A Securities | initiate | — → Neutral | $44 | 53% |
| Feb 27, 2023 | Lake Street | maintain | — → Buy | $60 | 47% |
| Dec 19, 2022 | Lake Street | initiate | — → Buy | $40 | 47% |
| Sep 21, 2022 | William Blair | initiate | — → Outperform | $0 | 48% |
| Aug 8, 2022 | Barclays | maintain | — → Equal-Weight | $57 | 53% |
| Aug 12, 2021 | Barclays | initiate | — → Equal-Weight | $92 | 53% |
Price Target Trend
Apr 17, 2026 Latest: $51.67 Oct 25, 2026
EPS Estimates
0q $0.88
Lo: $0.83 Hi: $0.91
3 analysts ▲2
+1y $3.64
Lo: $3.41 Hi: $3.83
3 analysts ▲2
0y $3.07
Lo: $2.94 Hi: $3.14
3 analysts ▲2
+1q $0.65
Lo: $0.57 Hi: $0.71
3 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days